VYNE Therapeutics
VYNE
#9861
Rank
S$28.05 M
Marketcap
$1.84
Share price
-2.08%
Change (1 day)
-48.49%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$15.09

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$14.44. In 2022 the company made an earnings per share (EPS) of -$9.59 an increase over its 2021 EPS that were of -$33.91.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$15.0957.35%
2022-$9.59-71.72%
2021-$33.91-84.19%
2020-$214.50-26.29%
2019-$291.0228.75%
2018-$226.0410.79%
2017-$204.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.85-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA